Advanced Search

Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2016 August;64(4) > Minerva Cardioangiologica 2016 August;64(4):473-80

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Frequency: Bi-Monthly

ISSN 0026-4725

Online ISSN 1827-1618

 

Minerva Cardioangiologica 2016 August;64(4):473-80

NEW BIORESORBABLE TECHNOLOGY IN INTERVENTIONAL CARDIOLOGY 

    REVIEWS

Overview of the clinical trials on bioresorbable vascular scaffold

Angela FERRARA 1, Giuseppe DI GIOIA 2, Teresa STRISCIUGLIO 2, William WIJNS 1, Emanuele BARBATO 1, 2

1 Cardiovascular Research Center Aalst, OLV Hospital, Aalst, Belgium; 2 Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy

Although several new scaffolds are progressively being investigated and entering the clinical scene, BRS has accumulated the largest experience by far including detailed evaluation of the first patients studied followed almost in parallel by clinical evaluation and worldwide randomized evaluation for non-inferiority against best contemporary metallic DES. Available evidence shows that careful procedural technique is required for proper and safe delivery of the current generation scaffolds. Future studies will indicate whether all or only selected patient or lesion subsets will ultimately benefit from treatment with fully bioresorbable devices.

language: English


FULL TEXT  REPRINTS

top of page